Get the Daily Brief
Latest Biotech News
Therapeutic and Diagnostic Advances in Cardiovascular and Metabolic Diseases
Research is progressing with novel biomarkers, therapies, and diagnostics addressing cardiovascular and metabolic conditions. Studies identified imidazole propionate (ImP), a gut microbiota...
Sustained Growth and Strategy Shifts in Biotech and Pharma Markets
Despite industry-wide challenges including tightening venture funding and regulatory uncertainty, key biotech and pharma companies are adjusting strategies to sustain growth. Novartis named a new...
Cancer and Rare Disease Therapy Developments and Clinical Updates
Leading biopharma companies report key advances and challenges in cancer and rare disease therapeutics. Diamedica demonstrated early efficacy of DM199 in preeclampsia, an area with no approved...
Advances in Neuroscience Technologies and Discoveries
Neuroscience research sees innovations ranging from brain activity imaging to understanding pain and sleep. Stanford researchers developed ultra-sensitive optical instruments using genetically...
Regulatory, Policy, and Market Impacts on Biotech and Healthcare
Regulatory and policy developments continue to influence the biotech sector broadly. The UK government announced plans to reduce drug and medical device approval costs by 25% over the next decade...
Sarepta Restructures Amid Safety Warnings, Lays Off 500 Staff
Sarepta Therapeutics is undergoing a significant strategic restructuring following safety concerns related to its Duchenne muscular dystrophy (DMD) gene therapy, Elevidys. The company announced a...
Mitochondrial Disease Breakthrough with Three-Person IVF Births
Researchers in the U.K. have reported the successful birth of eight healthy babies using mitochondrial donation and pronuclear transfer to prevent mitochondrial DNA diseases. This three-person IVF...
FDA Raises Concerns Over GSK’s Blenrep Safety and Efficacy
The FDA’s Oncologic Drugs Advisory Committee reviewed GSK's Blenrep (belantamab mafodotin) for multiple myeloma, expressing concerns regarding high rates of ocular toxicity including severe vision...
US Life Sciences Workforce Growth Slows Amid Economic Challenges
A comprehensive report from the Life Sciences Workforce Collaborative and Teconomy Partners LLC shows a slowing growth rate in the US life sciences sector, with industry-wide hiring down slightly...
Thermo Fisher to Acquire Sanofi’s Sterile Manufacturing Facility
Thermo Fisher Scientific announced its agreement to acquire Sanofi’s Ridgefield, New Jersey sterile fill-finish and packaging site. The acquisition will broaden Thermo Fisher’s US manufacturing...
AI-Powered Spatial Transcriptomics Study on Cancer Launched by A*STAR and 10x Genomics
Singapore’s A*STAR and 10x Genomics announced a collaboration for the TISHUMAP project, employing high-resolution spatial transcriptomics and AI to analyze up to 2,500 clinical samples from...
Novartis Appoints Mehta as CFO, Adjusts Income Guidance
Novartis has named its new Chief Financial Officer, Mehta, as part of management updates. The Swiss pharma company slightly raised its full-year sales guidance despite reporting Q2 sales figures...
Johnson & Johnson Reports Robust Q2 Led By Med-Tech and Innovative Drugs
Johnson & Johnson posted strong second-quarter 2025 results, driven by 22.3% growth in cardiology and 13% growth across its med-tech segments. Innovative medicines grew nearly 5%, offsetting a 43%...
Medicare Proposes Coverage Changes Limiting Transplant Surveillance Tests
Medicare contractor Palmetto’s MolDx program proposed new local coverage determinations restricting the number of surveillance tests allowable for transplant patients to monitor allograft...
Sarepta restructures with layoffs and pipeline pivot after DMD therapy deaths
Sarepta Therapeutics announced a major restructuring involving the layoff of approximately 500 employees, or 36% of its workforce, to achieve annual cost savings of around $400 million. This move...
FDA debates GSK’s Blenrep amid ocular toxicity concerns
GSK's antibody-drug conjugate Blenrep for multiple myeloma faces scrutiny over its safety and efficacy from the FDA's Oncologic Drugs Advisory Committee. Originally approved in 2020, the drug was...
Johnson & Johnson posts strong Q2 sales despite Stelara patent cliff
Johnson & Johnson reported robust second-quarter results with overall sales reaching $23.7 billion, a 4.6% increase year-over-year, driven by strong medical device performance and innovative...
NIST releases consented pancreatic cancer genomic dataset
The National Institute of Standards and Technology (NIST) has published a comprehensive genomic dataset derived from the pancreatic cancer cells of a 61-year-old patient who explicitly consented...
Mitochondrial donation yields eight healthy babies, advancing IVF therapy
Researchers in the United Kingdom have reported the birth of eight healthy children using mitochondrial donation techniques designed to prevent the transmission of mitochondrial DNA diseases. The...
Thermo Fisher to acquire Sanofi sterile manufacturing site in NJ
Thermo Fisher Scientific has agreed to acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, New Jersey. This site will expand Thermo Fisher's pharmaceutical manufacturing...